Condition: New.
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 252.82
Quantity: Over 20 available
Add to basketCondition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 252.74
Quantity: Over 20 available
Add to basketCondition: New.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 262.03
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 262.03
Quantity: Over 20 available
Add to basketCondition: New. In.
Condition: As New. Unread book in perfect condition.
Condition: As New. Unread book in perfect condition.
Condition: New. pp. 522 Softcover reprint of the original 1st ed. 2015 edition NO-PA16APR2015-KAP.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 291.59
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
US$ 291.58
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Condition: New.
Language: English
Published by Springer US, Springer New York, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 353.09
Quantity: 2 available
Add to basketPaperback. Condition: Brand New. reprint edition. 522 pages. 9.25x6.10x1.18 inches. In Stock.
Seller: Revaluation Books, Exeter, United Kingdom
US$ 355.46
Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 511 pages. 9.25x6.25x1.25 inches. In Stock.
Condition: new. Questo è un articolo print on demand.
Condition: new. Questo è un articolo print on demand.
Seller: moluna, Greven, Germany
US$ 216.25
Quantity: Over 20 available
Add to basketGebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Addresses the challenge to more efficiently select better molecules for drug developmentDiscusses how to expand the chemical space within which a pharmacological benefit can be foundExamines the real value of discovery-oriented pharmac.
Seller: moluna, Greven, Germany
US$ 216.25
Quantity: Over 20 available
Add to basketCondition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Addresses the challenge to more efficiently select better molecules for drug developmentDiscusses how to expand the chemical space within which a pharmacological benefit can be foundExamines the real value of discovery-oriented pharmac.
Language: English
Published by Springer New York Okt 2014, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state properties and critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings. 524 pp. Englisch.
Language: English
Published by Springer New York Sep 2016, 2016
ISBN 10: 1493948601 ISBN 13: 9781493948604
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state properties and critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings. 524 pp. Englisch.
Seller: Majestic Books, Hounslow, United Kingdom
US$ 305.83
Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 522.
Language: English
Published by Springer, Humana Sep 2016, 2016
ISBN 10: 1493948601 ISBN 13: 9781493948604
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 524 pp. Englisch.
Language: English
Published by Springer US, Springer New York Okt 2014, 2014
ISBN 10: 1493913980 ISBN 13: 9781493913985
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This authoritative volume provides a contemporary view on the latest research in molecules with optimal drug-like properties. It is a valuable source to access current best practices as well as new research techniques and strategies. Written by leading scientists in their fields, the text consists of fourteen chapters with an underlying theme of early collaborative opportunities between pharmaceutical and discovery sciences. The book explores the practical realities of performing physical pharmaceutical and biopharmaceutical research in the context of drug discovery with short timelines and low compound availability. Chapters cover strategies and tactics to enable discovery as well as predictive approaches to establish, understand and communicate risks in early development. It also examines the detection, characterization, and assessment of risks on the solid state properties of advanced discovery and early development candidates, highlighting the link between solid state propertiesand critical development parameters such as solubility and stability. Final chapters center on techniques to improve molecular solubilization and prevent precipitation, with particularly emphasis on linking physiochemical properties of molecules to formulation selection in preclinical and clinical settings.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 524 pp. Englisch.
Condition: New. PRINT ON DEMAND pp. 522.
Seller: Majestic Books, Hounslow, United Kingdom
US$ 327.83
Quantity: 4 available
Add to basketCondition: New. Print on Demand.
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND.